HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reiko Tanaka Selected Research

trichocellin

5/2007A functionalized 20-residue peptaibol derivative for nucleic acid delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Reiko Tanaka Research Topics

Disease

36Neoplasms (Cancer)
02/2022 - 12/2002
22Infections
02/2020 - 04/2003
17Carcinogenesis
08/2011 - 07/2003
9T-Cell Leukemia (Leukemia, T Cell)
01/2022 - 05/2013
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2022 - 05/2013
5Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2018
3Cysts
01/2018 - 04/2012
3Leukemia
04/2014 - 03/2005
3Papilloma (Papillomatosis)
11/2008 - 07/2006
2Hereditary leiomyomatosis and renal cell cancer
01/2021 - 12/2020
2Inflammation (Inflammations)
01/2020 - 05/2013
2Body Weight (Weight, Body)
09/2019 - 03/2010
2Vesicular Stomatitis
01/2018 - 04/2011
2Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
04/2016 - 05/2013
2Experimental Melanoma
08/2012 - 07/2012
2Carcinoma (Carcinomatosis)
05/2007 - 04/2006
1Cardiac Arrhythmias (Arrythmia)
03/2022
1Hypoglycemia (Reactive Hypoglycemia)
03/2022
1Critical Illness (Critically Ill)
03/2022
1Takotsubo Cardiomyopathy
03/2022
1Low Cardiac Output
03/2022
1Refeeding Syndrome
03/2022
1Uterine Neoplasms (Uterine Cancer)
02/2022
1Hyperglycemia
08/2021
1Hepatocellular Carcinoma (Hepatoma)
08/2021
1Arthritis (Polyarthritis)
01/2020
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Ulcerative Colitis
01/2020
1Ileitis
01/2020
1Hypertriglyceridemia
09/2019
1Insulin Resistance
09/2019
1Myoepithelioma
03/2019

Drug/Important Bio-Agent (IBA)

14TriterpenesIBA
04/2014 - 07/2003
10anthraceneIBA
08/2011 - 07/2003
8Epstein-Barr virus early antigenIBA
04/2014 - 09/2004
7Proteins (Proteins, Gene)FDA Link
01/2018 - 04/2005
5Pharmaceutical PreparationsIBA
01/2020 - 11/2006
5Monoclonal AntibodiesIBA
02/2016 - 10/2010
4Fumarate Hydratase (Fumarase)IBA
01/2021 - 01/2018
4VaccinesIBA
01/2020 - 08/2003
4ChemokinesIBA
11/2013 - 02/2006
3Messenger RNA (mRNA)IBA
01/2018 - 03/2015
3Glycoproteins (Glycoprotein)IBA
01/2018 - 04/2011
3AntigensIBA
01/2017 - 04/2014
3Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
01/2009 - 04/2005
3AcidsIBA
05/2007 - 03/2005
3SolutionsIBA
05/2007 - 07/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2006 - 04/2005
2EpitopesIBA
01/2020 - 10/2011
2Transcription Factors (Transcription Factor)IBA
08/2019 - 08/2012
2Microphthalmia-Associated Transcription FactorIBA
08/2019 - 03/2019
2Estrogen ReceptorsIBA
03/2019 - 01/2014
2Trans-Activators (Trans-Acting Factor)IBA
11/2016 - 05/2013
2Acetates (Acetic Acid Esters)FDA Link
04/2014 - 08/2006
2Melanocyte-Stimulating Hormones (MSH)IBA
08/2012 - 07/2012
2Monophenol Monooxygenase (Tyrosinase)IBA
08/2012 - 07/2012
2Melanins (Melanin)IBA
08/2012 - 07/2012
2LigandsIBA
10/2011 - 09/2011
2OX40 LigandIBA
04/2011 - 10/2010
2Peroxynitrous Acid (Peroxynitrite)IBA
09/2010 - 09/2009
23beta-methoxyserrat-14-en-21beta-olIBA
06/2010 - 10/2004
213alpha,14alpha- epoxy- 3beta- methoxyserratan- 21beta- olIBA
03/2010 - 10/2004
2CarcinogensIBA
03/2010 - 03/2005
2oleananeIBA
07/2009 - 03/2005
2LupanesIBA
07/2009 - 12/2004
2InterleukinsIBA
01/2008 - 02/2006
2lupaneIBA
08/2006 - 03/2005
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
02/2006 - 04/2005
1Glucose (Dextrose)FDA LinkGeneric
03/2022
1CatecholaminesIBA
03/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1ImmunosorbentsIBA
01/2022
1EnzymesIBA
01/2022
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2022
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2022
1Bevacizumab (Avastin)FDA Link
08/2021
1C-PeptideIBA
08/2021
1Insulin (Novolin)FDA Link
08/2021
1atezolizumabIBA
08/2021
1NivolumabIBA
01/2021
1IpilimumabIBA
01/2021
1Peptide Hydrolases (Proteases)FDA Link
02/2020
1Inosine Triphosphate (ITP)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
09/2019
1LimoninsIBA
09/2019
1Mucin-1 (CA 15-3 Antigen)IBA
03/2019
1Glial Fibrillary Acidic ProteinIBA
03/2019
1S100 Proteins (S 100 Protein)IBA
03/2019

Therapy/Procedure

5Therapeutics
08/2021 - 01/2010
3Immunotherapy
01/2021 - 06/2008
3Oral Administration
07/2009 - 07/2006
2Nephrectomy
05/2018 - 01/2018
2Chemoprevention
04/2014 - 09/2010
2Ligation
11/2013 - 10/2011
1Glycemic Control
03/2022
1Brachytherapy
02/2022
1Re-Irradiation
02/2022
1Colectomy
01/2020